Results 141 to 150 of about 104,894 (342)
Fundamento: en el municipio Puerto Padre han ido aumentando paulatinamente los pacientes con el diagnóstico de cáncer de colon y recto.Objetivo: caracterizar a los pacientes operados de cáncer colorrectal en el servicio de cirugía del hospital “Guillermo
Jorge Luis Montes-de-Oca-Mastrapa +1 more
doaj
COULD THE ENDOSCOPIC RESECTION OF A LARGE RECTAL LEIOMYOMA BE AN EFFETCIVE AND SAFE TECHNIQUE? [PDF]
Summary. Rectal leiomyomas are a rare conditions, with low reported incidence in literature and constitute about 0.1% of rectal tumours; in fact rectal leiomyomas occur in approximately 1 out of 2000-3000 rectal tumors. We report on a patient with a 3 cm
Amvrosiadis, G. +14 more
core
Clinical Significance of Copper Chaperone for Superoxide Dismutase in Colorectal Cancer
ABSTRACT Background Targeting Cu transport proteins is an innovative therapeutic approach for combating cancer. However, the mechanisms underlying the malignant potential of Cu transport proteins remain largely unknown. To address this issue, we focused on the oncogenic potential of copper chaperones for superoxide dismutase (CCS) in colorectal cancer (
Nobuo Takiguchi +15 more
wiley +1 more source
Oviductal and uterine leiomyomata in mares [PDF]
This paper describes a case of a sessile uterine leiomyoma in a 17-year-old chronic infertile Selle Francais mare. The mass was removed by transendoscopic electrocoagulation.
Chiers, Koen +5 more
core
This review critically reassesses our prior hypothesis and proposes a revised anatomical model of the fusion fascia that is broadly applicable to GI cancer surgeries grounded in the principles of mesenteric resection. Our synthesis suggests that the fusion fascia is neither a dense connective tissue membrane nor a remnant of mesothelial fusion, but ...
Hisashi Shinohara +9 more
wiley +1 more source
Total Neoadjuvant Therapy for Rectal Cancer: Why Japan Says “Not Yet”
ABSTRACT Total neoadjuvant therapy (TNT) has rapidly gained global acceptance as a standard treatment for locally advanced rectal cancer (LARC). Supported by multiple phase III trials, TNT improves pathological complete response (pCR) rates, enhances systemic control, and expands opportunities for non‐operative management (NOM).
Kay Uehara +4 more
wiley +1 more source
Chemoradiotherapy response in recurrent rectal cancer. [PDF]
Bhangu, A +5 more
core +1 more source
SpaceOAR to improve dosimetric outcomes for monotherapy high-dose-rate prostate implantation in a patient with ulcerative colitis. [PDF]
High-dose-rate (HDR) brachytherapy is an attractive option for patients receiving definitive radiation therapy for prostate cancer with decreased overall dose to the pelvis.
Den, Robert B. +4 more
core +1 more source
This retrospective study explored the potential impact of renin–angiotensin system inhibitors (RASIs) on renal function during the ileostomy period in patients undergoing rectal cancer surgery. RASI use was associated with early postoperative renal impairment, and relatively slow recovery of renal function was observed until stoma closure.
Yusaku Shogen +6 more
wiley +1 more source

